The Middle EAST Breast Biopsy Devices Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is underpinned by increasing awareness regarding breast cancer screening and diagnosis, coupled with advancements in biopsy technologies. The rising prevalence of breast cancer in the region has led to a surge...